Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Chemotherapy At Home Services Industry Expected To Reach By 2029, Starting From 2025 Levels?
The chemotherapy at home services market size has experienced rapid expansion in recent years. This market is projected to expand from $1.75 billion in 2024 to $1.94 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.1%. Historically, this growth has been driven by factors such as a rise in cancer cases, increasing patient preference for home-based care, limitations in hospital capacity, enhanced home healthcare infrastructure, and favorable government regulations.
The chemotherapy at home services market size is anticipated to undergo swift expansion in the next few years, projected to reach $2.89 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.4%. This upward trajectory during the forecast period is driven by factors such as escalating healthcare expenditures, an aging global demographic, the broadening of home healthcare provisions, a heightened focus on patient-centric services, a greater need to reduce inpatient hospital stays, and advancements in chronic disease management. Noteworthy trends identified for the forecast period include the integration of AI and machine learning, the adoption of personalized medicine approaches, the proliferation of wearable health technology, an increase in specialty home infusion services, and the development of collaborative healthcare models.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15762&type=smp
Which Drivers Are Shaping The Chemotherapy At Home Services Industry’s Market Share?
The rising incidence of cancer is anticipated to fuel the expansion of the chemotherapy-at-home services market in the future. This condition involves the uncontrolled proliferation and spread of abnormal cells throughout the body. The heightened occurrence of cancer stems from various elements, including an aging demographic, shifts in lifestyle, exposure to environmental factors, genetic predispositions, and improved identification via sophisticated diagnostic methods. Services delivering chemotherapy at home enable individuals with cancer to undergo treatment in their personal residences, thereby enhancing convenience and the overall quality of life. As an illustration, data from January 2023, reported by the National Center for Biotechnology Information, a US-based intergovernmental organization, indicated that the United States anticipated 1,958,310 new cancer diagnoses and 609,820 cancer fatalities in 2023. Consequently, the growing prevalence of cancer is a key impetus for the expansion of chemotherapy at-home services.
What Are The Major Segment Categories Driving The Chemotherapy At Home Services Market Growth?
The chemotherapy at home servicesmarket covered in this report is segmented –
1) By Product: Chemotherapy Drugs; Chemotherapy Infusion Pumps
2) By Administration: Oral; Intravenous
3) By Application: Breast Cancer; Blood Cancer; Ovarian Cancer; Colorectal Cancer
Subsegments:
1) By Chemotherapy Drugs: Oral Chemotherapy Drugs; Injectable Chemotherapy Drugs; Targeted Therapy Drugs; Chemotherapy Regimen Combinations
2) By Chemotherapy Infusion Pumps: Portable Infusion Pumps; Home Infusion Therapy Pumps; Electronic Infusion Pumps; Ambulatory Infusion Pumps
What Key Innovation Trends Are Fueling Advancements In The Chemotherapy At Home Services Market?
Major companies within the chemotherapy-at-home services market are introducing pioneering chemotherapy care services, aiming to transform the delivery of chemotherapy treatments and significantly enhance patient safety and convenience. This chemotherapy care service involves administering treatment directly within the comfort and convenience of patients’ homes. For example, in September 2022, Jivika Healthcare, an India-based mobile medical service provider, launched ChemoAtHome, a dedicated chemotherapy care service for cancer patients. This service provides safe and high-quality cancer care, administered by trained nurses under the oversight of an MBBS doctor, by creating hospital-like setups in patients’ homes. ChemoAtHome aims to deliver convenience and financial benefits, with potential savings of up to 20% to 25% on chemotherapy hospital bills. The service also encompasses pre and post-chemotherapy support, including video consultations with oncologists and the home-delivery of medicines.
Which Leading Players Are Enhancing Their Chemotherapy At Home Services Market Presence Worldwide?
Major companies operating in the chemotherapy at home services market are CVS Health Corporation, Optum Inc., Fresenius Kabi, Medtronic plc, Amgen, Penn Medicine, Advocate Health Care, Medibank Private Limited, Option Care Health Inc., Amedisys Inc., Lincare Holdings Inc., Cancer Treatment Centers of America (CTCA), BioScrip Inc., Shanghai MicroPort Lifesciences Co. Ltd., Accredo Health Group Inc., LloydsPharmacy Clinical Homecare, InfuSystem Holdings Inc., Portea Medical, Amerita Inc., Jivika Healthcare, Vitalis Health and Home Care Pty Ltd., Ubiqare Health Pvt. Ltd., View Health Pty Ltd group, Sciensus Pharma Services Limited, TCP Homecare
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report
Which Region Is Projected To Lead The Chemotherapy At Home Services Market During The Forecast Period?
North America was the largest region in the chemotherapy at-home services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy at home services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Chemotherapy At Home Services Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15762&type=smp
Browse Through More Reports Similar to the Global Chemotherapy At Home Services Market 2025, By The Business Research Company
Chemotherapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2025
Chemotherapy Induced Anemia Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model